Claybrook Capital’s AMN Healthcare AMN Stock Holding History

Claybrook Capital’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-699	Closed	-$40K	–	121
2018 Q4	$40K	Buy	+699	New	+$39.2K	0.01%	279

Other funds holding AMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Claybrook Capital's AMN Position: Q1 2019 in Review

Claybrook Capital sold out of AMN Healthcare (AMN) in Q1 2019, closing a stake of 699 shares — an estimated $40K sold.

Claybrook Capital first reported a position in AMN in Q4 2018 and held it in 1 quarter. The position peaked at $40K in Q4 2018. 311 funds tracked by Wall St. Rank hold AMN as of Q1 2019.

Claybrook Capital reported no remaining AMN Healthcare position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 699 AMN Healthcare shares in Q1 2019, an estimated $40K.
Claybrook Capital first reported a position in AMN Healthcare in Q4 2018 and held it in 1 quarter.
Claybrook Capital's AMN Healthcare position peaked at $40K in Q4 2018.
311 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.